This is not only due to the fact that investors are a temperamental bunch. The outcome of the trade disputes has a significant impact on corporate earnings, arguably a key determinant of equity allocation. There still remains uncertainty surrounding the trade conflict, not only between the US and China, but to a large degree between the US and the rest of the world.
This, combined with the intellectual property disputes in information technology, is having an impact on economic activity and earnings across the globe: directly (through higher costs and lower revenues) or indirectly (as companies refrain from spending or investing more). Brexit has been the other topic at the forefront of equity investors’ minds, although its impact is by and large contained to the UK and Continental European equity markets.
Depending on which one of our two scenarios (base case or alternative) develops over the next year, regional allocation in equity portfolios in our opinion should look very different.
Our base case scenario – with no hard Brexit and a slimmed-down version of a US-China trade deal; sufficient to bring back some business confidence, capital expenditures and corporate earnings growth – makes the case for equities outside of the US compelling. The current equity risk premium of US equities is at a 20-year low vis à vis Japan, Europe and emerging markets.
Arguably, US equity markets are discounting a world where US corporates are not only firing on at least most of their cylinders, but also where the rest of the world’s corporates remain far behind. However, a look at the current earnings expectations across major equity markets paints a very different picture. Markets outside the US have already priced in a lot of uncertainty, and earnings growth (or lack thereof) is now at levels that do not justify the wide disparity in valuations.
Take EM, with an expected earnings growth of 2.3% for 2019 and 13.4% for 2020, and a P/E of 13.2x and 11.4x, respectively. This compares with the US’s 2.3% and 10.5% 2019 and 2020 earnings growth and 18.6x and 16.9x P/E, respectively. For Japan, earnings are expected to fall by 0.9% in 2019 and grow 5.8% in 2020, while P/E is at 13.7x and 12.8x, respectively. Europe’s earnings expectations are for a 1.3% and 9.7% growth respectively, priced at a P/E of 14.8x and 13.4x.
The relative earnings outlook is a key driver for regional allocation in equity markets. This is most evident in emerging markets, where their relative performance to developed markets over the long term has coincided with the forward earnings gap (see the graph below).
Of course, for equities outside of the US to outperform, we need their earnings expectations not to fall below their current levels. A poor earnings environment would set markets back on the defensive and quality-seeking path into the arms of US equities. That macro improvement, that is part of our base case scenario, is therefore a key prerequisite to support earnings.
The case for outperformance of non-US equity markets becomes even more compelling given the persistent underperformance that we have witnessed over the last ten years, as shown in the following graph.
In our alternative scenario, which in our view is less likely, we have either no resolution or a meaningful setback in the US-China negotiations, the path to a US recession is already irreversible, and corporate earnings across the world weaken. Such a scenario would most likely bring back the risk-off stance, with global equity markets underperforming other asset classes and, within equities, the US market and more defensive bets most likely prevailing.
Depending on which one of our two scenarios develops over the next year, regional allocation in equity portfolios should look very different. In our base case scenario, the case for equities outside of the US is compelling, given relative earnings growth, valuations and prolonged underperformance. In this scenario, there is no hard Brexit and a slimmed-down version of a US-China trade deal, sufficient to bring back some business confidence, capital expenditures and a return of corporate earnings growth.
Our alternative scenario would most likely bring back the risk-off stance. Within equities, the US market and more defensive bets would probably prevail. That said, we see the risk-reward between the two scenarios as asymmetric. Further degeneration in either the trade war or Brexit is likely to cause a negative price reaction, the latter limited to the UK and Europe. But the upside to non-US equities that would be triggered by positive news at this point looks far greater.
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.